Merck beats Q1 forecasts, helped by Januvia, animal health brands

April 28, 2015 11:17 AM

17 0

April 28 (Reuters) - Merck & Co reported better than expected quarterly sales and earnings, helped by sales of its Januvia diabetes drug and its animal health products.

The U.S. drugmaker on Tuesday said it earned $953 million, or 33 cents per share, in the first quarter. That compared with $1.71 billion, or 57 cents per share, in the year earlier period.

Also read: Bayer faces U.S. antitrust hurdles for Monsanto merger: Bloomberg

Read more

To category page